Population Pharmacokinetics and Dosing Recommendations for Cisplatin during Intraperitoneal Peroperative Administration-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Population Pharmacokinetics and Dosing Recommendations for Cisplatin during Intraperitoneal Peroperative Administration

Published:2009 Issue:3 Volume:48 Page:169-180
ISSN:0312-5963
Container-title:Clinical Pharmacokinetics
language:en
Short-container-title:Clinical Pharmacokinetics

Author:

Royer Bernard,Jullien Vincent,Guardiola Emmanuel,Heyd Bruno,Chauffert Bruno,Kantelip Jean-Pierre,Pivot Xavier

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology

Reference40 articles.

1. Descriptive epidemiology of ovarian cancer in the United States, 1992-1997

2. Incidence of ovarian cancer by race and ethnicity in the United States, 1992-1997

3. Medical treatment of resistant or recurrent epithelial ovarian cancer

4. Standard treatment in advanced ovarian cancer in 2005: the state of the art

5. 2004 consensus statements on the management of ovarian cancer: final document of the 3rd International Gynecologic Cancer Intergroup Ovarian Cancer Consensus Conference (GCIG OCCC 2004)

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PKPD Modeling and Dosing Considerations in Advanced Ovarian Cancer Patients Treated with Cisplatin-Based Intraoperative Intraperitoneal Chemotherapy;The AAPS Journal;2020-07-24

2. Update on Intraperitoneal Chemotherapy for the Treatment of Epithelial Ovarian Cancer;American Society of Clinical Oncology Educational Book;2016-05

3. Analytical Approaches for Assaying Metallodrugs in Biological Samples: Recent Methodological Developments and Future Trends;Current Drug Metabolism;2012-03-01

4. Intraperitoneal clearance as a potential biomarker of cisplatin after intraperitoneal perioperative chemotherapy: a population pharmacokinetic study;British Journal of Cancer;2011-12-15

5. Reducing excessive toxicity in ovarian cancer treatment: a personalized approach;Future Oncology;2011-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3